Category: Doctor’s Blog

26

Feb2020
The Wall Street Journal published an article on ADHD in older adults over age 50. Quoted in the article, I helped provide important information on this subject. Highlighting why ADHD needs to be considered in older adults complaining of cognitive difficulties, the article serves to increase public awareness on a ... Read More
February 26, 2020David W. Goodman, MD

26

Feb2020
Distinguishing clinical depression from ADHD in adults may be difficult for patients and clinicians. Adults with ADHD may complain about being depressed because they are about to lose their job, get separated from their spouse, or some other "really bad thing" happening in their lives. This "bad" circumstance may have ... Read More
February 26, 2020David W. Goodman, MD

09

Feb2020
A faculty speaker for the Neuroscience Education Institute (NEI) for many years, I have been invited to present several talks on adult ADHD and the complexity of medications. There are currently 28 different ADHD stimulant preparations (my last count). While there are only 4 different chemical compounds (methylphenidate, d-methylphenidate, amphetamine, ... Read More
February 9, 2020David W. Goodman, MD

01

Jan2020
Dr. David W. Goodman has been invited as a panelist to discuss clinical implications of adult ADHD research and the use of medications in complex treatment. APSARD, American Professional Society for ADHD and Related Disorders, is a nationally and internationally represented professional organization devoted to the advancement of ADHD ... Read More
January 1, 2020David W. Goodman, MD

21

Sep2019
NYU Langone Health conference on Adult ADHD will feature international experts Dr. Len Adler, Dr. Joseph Beiderman, Dr. Francisco X. Castellanos and others. I am honored to be invited as faculty to present the latest science on ADHD in older adults (over the age of 50). My presentation will cover ... Read More
September 21, 2019David W. Goodman, MD

26

Mar2019
This month Enzymotec, the makers of Vayarin, quietly announced on their website that they would no longer sell its product in the U.S. This leaves patients who have been taking it in a quandary without support. While the company’s announcement cites “a lack of alignment with our business strategy” as an explanation, no one ... Read More
March 26, 2019David W. Goodman, MD

22

Mar2019
Stimulants for ADHD and risk of psychosis has been a clinical concern but the risk has thought to be quite low. Dr. Goodman's comments about the study can be read here. The recent New England Journal of Medicine study has demonstrated the risk of psychosis with amphetamines is 0.2% and ... Read More
March 22, 2019David W. Goodman, MD

07

Mar2019
Parenting an ADHD child is challenging. Yet, this challenge is heightened when one or both of the parents have ADHD. While consistent behavioral routines are advocated in ADHD households, untreated ADHD parents will have great difficulty executing consistent oversight of their children. from Today.com reviewed a video of a family whose ... Read More

07

Mar2019
CVS CAREMARK CRITERIA Starting January 1, 2018, these patients may not be able to fill their current medication at the pharmacy, based on the plan's coverage changes. Please visit caremark.com/highvalueplan to review the coverage details of this pharmacy benefit plan.   PA                                    = Prior Authorization                                    There must be a satisfied PA on ... Read More

07

Mar2019
UnitedHealthCare/Optum were cited by the court to have created internally generated algorithms for mental health care that fell short of acceptable standards for professional psychiatric associations. Your frustration from inadequate coverage now has a reason. Read the following details from the Psychiatric News March 7, 2019. UBH Found to Have Wrongfully ... Read More